CYCLOPHARM
Jubilant, Cyclopharm terminate pact for Technegas in US marketTechnegas is an imaging agent primarily used in Pulmonary Embolism (blockage of lung arteries). At present, it is sold in 55 countries incl...11 May, 2016, 06.26 PM IST
Jubilant to market Technegas in US; signs pact with CyclopharmJubilant Life Sciences said its subsidiary Jubilant DraxImage Inc has signed a term sheet with Cyclopharm for licence to market Technegas i...14 Sep, 2015, 12.22 PM IST
Load More